Market intelligence for the Slovak pharma market

Drug consumption, reimbursement, competition and patients in the Slovak pharma market — in one dashboard.

Datalytica connects public NCZI, ŠÚKL and MoH SR data into insights for market-access, commercial and BI teams. Every figure carries its source, period and update frequency.

Request a demo See dashboard preview
Data sources: NCZIŠÚKLMZ SR

Every view states its source and period. Datalytica does not work with "today's" data across the board — it reflects the latest published period of each source (consumption quarterly, registries yearly, categorisation proceedings daily).

Market overview SR · 2025
Last available period
Celkový trh+6,2 %
€2,14 mld.
Insurer reimbursement+4,1 %
€1,38 mld.
Predané balenia+2,8 %
312 mil.
Rast medziročneYoY
+5,9 %
Market evolution12 mesiacov
Market by segmentpodiel €
€2,1 mld. ročne
Lieky na predpis38%
Voľnopredajné27%
Zdrav. pomôcky20%
Dietetické15%
Top therapy areaspodiel trhu
Market leadersdržitelia reg.
100 %
public, verifiable data
12+ modules
from category to brand
€ and packages
market shares in both metrics
0 Excelov
no manual data downloads
Problem

Public data exists. The problem is turning it into business insight.

NCZI, ŠÚKL and the MoH SR publish a wealth of data on consumption, prices and reimbursement. But processing it manually is time-consuming, opaque and hard to use for decisions.

Dozens of disjointed Excel exports
Hours of manual cleaning and merging
No single view of the market
Solution

Datalytica turns public data into a clear dashboard.

The platform automatically processes available Slovak data and turns it into market insights that help track competition, shares, trends and opportunities.

Public data
NCZI · ŠÚKL · MZ SR
Processing
cleaning and standardisation
Analytics
shares, trends, competition
Decisions
a clear dashboard
What you see in the platform

From category down to a specific brand.

Who it's for

For teams that need to see the market without unnecessary complexity.

One system that speaks the language of market access, sales and analytics — with no needless onboarding.

Platform previews

See the views you will actually get.

31 views in four groups — from the whole market through competition to diagnoses and regions. Pick a quarter or a full year, with complete lists of molecules and segments. Click to switch between previews.

Datalytica/Celý trh
Last available period

Sample views with real 2025 data. Some views are available in higher plans.

Data and sources

Built on verified public Slovak sources.

Datalytica works with publicly available Slovak data and processes it into usable analytics for decisions on the national market.

NCZI
National Health Information Center — consumption and dispensing.
ŠÚKL
State Institute for Drug Control — registrations and prices.
MZ SR
Ministry of Health SR — reimbursement and categorisation.
Use cases

Data that leads to concrete decisions.

Competition
See who took your market share
The Competitor War Room shows which segments you're losing and which rival is growing at your expense.
Market-access
Track how the patient co-payment changed after categorisation
See changes in reimbursement and patient co-payment after categorisation proceedings — where it rose, where it fell and what that means for demand.
Sales
Compare your company with rivals within one ATC group
Share in packages and euros, trend and ranking — your brand next to rivals in the same segment.
Strategy
Find categories growing faster than the market
Spot above-average growth segments before competitors do — where to steer your portfolio and sales.
Commercial
Build a commercial case with numbers
Ammunition for talks with pharmacies, distributors or central procurement — market size, shares and trends in one place.
Launch
Check whether a new product really grows after launch
Track a new product's ramp-up quarter by quarter and compare it with the whole category's dynamics.
Why Datalytica

Why Datalytica and not Excel or a plain data export?

You can download public data yourself. The question is how many hours it costs you — and whether you get a decision out of it, or just another spreadsheet.

Manual ExcelPlain data exportDatalytica
Market size and sharesManual calculation, hours of workRaw numbers to crunchDone — shares, ranking, trend
Competition in one viewNoPartlyYes — who's growing and who's losing
Readability for managementSpreadsheetsSpreadsheetsManagement dashboard
Your company vs the marketManuallyNoAutomatically — YOU vs the market
Data cleaning and linkingOn youRaw, not standardisedContinuous, via codes (ATC, ŠÚKL, ICD-10)
Commercial recommendationNoNoYes — what to do about it

Datalytica doesn't sell you data. It shows you what's happening in your market and what decision to make.

FAQ

Frequently asked questions

Practical answers to what companies ask most before getting started.

Where does the data come from?
From official public sources — NCZI, ŠÚKL and the Slovak Ministry of Health. We clean, link and aggregate the data into clear dashboards; we work with no non-public or personal data.
Why pay for public data?
Public data is available, but it is not ready for decision-making. Datalytica regularly downloads, cleans and links it via codes (ATC, ŠÚKL, ICD-10), unifies company names, computes shares, trends and segment differences — and shows it in one dashboard, with source and period on every figure. You save dozens of hours of manual work in Excel.
How up to date is the data?
Frequency depends on the source — for every dataset the pricing states which period it covers. NCZI drug consumption, for example, is quarterly. We never show running same-day figures; always closed, verified periods.
What does “€” mean in the platform — is it the company's revenue or sales?
No. “€” is the health-insurer reimbursement for covered (categorised) items — the flow of public money, not a company's revenue, turnover or selling price. It shows the market's value from the reimbursement side, not any single company's accounting.
How do you calculate a company's market share?
By the marketing-authorisation holder (MAH) — who places the product on the market — not the physical manufacturer. We keep the manufacturer as a supplementary audit attribute per product, so a “by holder” share can differ from a “by manufacturer” view. For devices and foods we use the supplier.
Why do your numbers differ from our internal sales data?
We work with consumption/dispensing from public sources (NCZI) — what actually passed through the reimbursement system — not your sell-in/sell-out. “€” also covers only categorised (reimbursed) items. It's a single, consistent whole-market view using the same methodology for every player — complementary to your internal data, not a replacement.
Do you cover only drugs, or also medical devices and dietary foods?
All three markets — drugs, medical devices and dietary foods — including shares, trends, competition and brands. You switch datasets directly in the app.
Can I track a specific brand, not just a company?
Yes. Besides the company (holder/supplier) you can analyse a specific brand — including a side-by-side comparison of two brands over time, in packages and in euro reimbursement.
Do we need to install anything or involve IT to get started?
No. Datalytica is a web application — all you need is a browser, and it works on mobile too. No installation, no integration into your systems, no maintenance on your side.
Where is the data hosted and who has access?
On servers in the EU (provider Hetzner, Germany), with e-mail via Websupport (SK) — both acting as GDPR processors. We work exclusively with public aggregated data; we store no patient or sensitive personal data. Access to your account is protected by sign-in.
Is the platform GDPR-compliant?
Yes. We work exclusively with aggregated, anonymised public market data — no individual patient or sensitive personal data.
How many users can our account have?
The licence is per company with an unlimited number of users — you don't pay per colleague.
Can I export the data?
Yes — in the Pro and Intelligence plans you can download the current view to CSV; Intelligence also includes API access.
How does billing work?
You choose what suits you: annual access (best value — you pay once for 12 months) or quarterly access with no commitment at a higher rate. In both cases you get access to all the data in your plan — historical and continuously updated. We invoice the company billing details you enter at registration. Prices exclude VAT.
Can I see historical data?
Yes. Drug consumption, medical devices and dietary foods run from 2020 (quarterly) up to the current quarter 2026-Q1 (preliminary); reimbursement € for devices and foods from 2024. Disease registers 2013–2024, oncology 2016–2024. The exact range and latest available period of every dataset is in the “Data recency & range” table in the pricing page. The range of unlocked periods depends on your plan.
How do we get started?
Fill in the Request-a-demo form or register. We activate the account manually and get back to you by e-mail; then you sign in and see the data unlocked according to your subscription.
Contact

Want to see your position on the market?

Get in touch and we'll show you a demo on your own segment — competition, shares and trends over time.

Operator
MEDIBEARS s. r. o.
Ulica J. Bendíka 738/6
971 01 Prievidza, Slovensko
IČO56 818 301
DIČ2122462584
IČ DPHSK2122462584
Registered in the Commercial Register of the District Court Trenčín, section Sro, entry No. 55562/R.
info@datalytica.sk